In the same study it was also found that Adavosertib resistance via AXL upregulation was mediated by the ERK/p90RSK signaling cascade, Akt/mTOR signaling and Chk1 activation in SCLC cell lines. The gene discussed is MTOR; the disease is small cell lung carcinoma.